[go: up one dir, main page]

CA2141039A1 - Formulations d'aerosol exemptes de surfactif, renfermant du dipropionate de beclomethasone - Google Patents

Formulations d'aerosol exemptes de surfactif, renfermant du dipropionate de beclomethasone

Info

Publication number
CA2141039A1
CA2141039A1 CA002141039A CA2141039A CA2141039A1 CA 2141039 A1 CA2141039 A1 CA 2141039A1 CA 002141039 A CA002141039 A CA 002141039A CA 2141039 A CA2141039 A CA 2141039A CA 2141039 A1 CA2141039 A1 CA 2141039A1
Authority
CA
Canada
Prior art keywords
aerosol formulations
beclomethasone dipropionate
formulations containing
surfactant free
free aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002141039A
Other languages
English (en)
Other versions
CA2141039C (fr
Inventor
Anthony James Taylor
Philip John Neale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929216382A external-priority patent/GB9216382D0/en
Priority claimed from GB929216381A external-priority patent/GB9216381D0/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1993/002040 external-priority patent/WO1994003153A1/fr
Publication of CA2141039A1 publication Critical patent/CA2141039A1/fr
Application granted granted Critical
Publication of CA2141039C publication Critical patent/CA2141039C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002141039A 1992-07-31 1993-07-30 Formulations d'aerosol exemptes de surfactif, renfermant du dipropionate de beclomethasone Expired - Fee Related CA2141039C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9216381.5 1992-07-31
GB929216382A GB9216382D0 (en) 1992-07-31 1992-07-31 Medicaments
GB9216382.3 1992-07-31
GB929216381A GB9216381D0 (en) 1992-07-31 1992-07-31 Medicaments
PCT/EP1993/002040 WO1994003153A1 (fr) 1992-07-31 1993-07-30 Formulations d'aerosol sans tensioactif contentant du dipropionate de beclomethasone

Publications (2)

Publication Number Publication Date
CA2141039A1 true CA2141039A1 (fr) 1994-02-17
CA2141039C CA2141039C (fr) 2006-04-25

Family

ID=36251280

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141039A Expired - Fee Related CA2141039C (fr) 1992-07-31 1993-07-30 Formulations d'aerosol exemptes de surfactif, renfermant du dipropionate de beclomethasone

Country Status (1)

Country Link
CA (1) CA2141039C (fr)

Also Published As

Publication number Publication date
CA2141039C (fr) 2006-04-25

Similar Documents

Publication Publication Date Title
HK130397A (en) Aerosol formulation comprising beclomethasone 17,21 dipropionate
EP1277467A3 (fr) Formulations d' aƩrosols sans chlorofluorohydrocarbures
GR3026185T3 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate.
AU3038197A (en) Aerosol formulations
CA2381329A1 (fr) Medicaments
CA2178473A1 (fr) Compositions d'aerosols a base de flunisolide
AU5306486A (en) Drug-containing chlorofluorocarbon aerosol propellent formulations
CA2004598A1 (fr) Aerosols medicinaux
CA2125667A1 (fr) Medicaments aerosols avec propulseur fluorocarbone
CA2317999A1 (fr) Formulation pharmaceutique de propionate de fluticasone
AU6882796A (en) Pharmaceutical compositions and devices for their administration
CA2141039A1 (fr) Formulations d'aerosol exemptes de surfactif, renfermant du dipropionate de beclomethasone
AU6326094A (en) New medicament aerosol formulation based on fusafungine, a process for its preparation and pharmaceutical compositions containing it
AU1534501A (en) Pharmaceutical formulations of salmeterol
CA2446562A1 (fr) Formulation pharmaceutique de propionate de fluticasone
MX9707238A (es) Formulaciones en aerosol de butixocort.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed